317. Trifunctional protein deficiency Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 6 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States
Nutritional ketone supplement
Oregon Health and Science University
2022 Early Phase 1 NCT05411835 United States
Triheptanoin
Jerry Vockley, MD, PhD
2009 - NCT01461304 United States
Vitamin E supplement
Oregon Health and Science University
2010 - NCT00840112 United States
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States
Nutritional ketone supplement
Oregon Health and Science University
2022 Early Phase 1 NCT05411835 United States
Triheptanoin
Jerry Vockley, MD, PhD
2009 - NCT01461304 United States
Vitamin E supplement
Oregon Health and Science University
2010 - NCT00840112 United States